P
Piston Bio develops novel therapeutic candidates focused on addressing unmet needs in oncology. The company utilizes proprietary platforms to engineer differentiated biological agents for cancer treatment. Their pipeline emphasizes achieving near-term clinical readouts for indications like cancer-related apathy.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Piston Bio develops novel therapeutics focused on inducing tumor antigens to enhance cancer immunotherapy responses. The company's platform aims to convert "cold" tumors into immunogenic environments for better patient outcomes. This approach leverages proprietary technology to improve the efficacy of existing checkpoint inhibitor treatments.